ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
10
views
0
references
Top references
cited by
44
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,285
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Glycemic control in patients with insulinoma treated with everolimus.
Author(s):
Emily K Bergsland
,
Matthew Kulke
,
James C Yao
Publication date:
2009-01-08
Journal:
The New England journal of medicine
Keywords:
Adult
,
Aged
,
Blood Glucose
,
metabolism
,
Female
,
Humans
,
Hypoglycemia
,
drug therapy
,
etiology
,
Immunosuppressive Agents
,
therapeutic use
,
Insulinoma
,
complications
,
Male
,
Middle Aged
,
Pancreatic Neoplasms
,
Sirolimus
,
analogs & derivatives
,
Young Adult
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
A Sustainable Future
Author and article information
Journal
DOI::
10.1056/NEJMc0806740
PubMed ID::
19129539
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Aged
,
Blood Glucose
,
metabolism
,
Female
,
Humans
,
Hypoglycemia
,
drug therapy
,
etiology
,
Immunosuppressive Agents
,
therapeutic use
,
Insulinoma
,
complications
,
Male
,
Middle Aged
,
Pancreatic Neoplasms
,
Sirolimus
,
analogs & derivatives
,
Young Adult
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Aged
,
Blood Glucose
,
metabolism
,
Female
,
Humans
,
Hypoglycemia
,
drug therapy
,
etiology
,
Immunosuppressive Agents
,
therapeutic use
,
Insulinoma
,
complications
,
Male
,
Middle Aged
,
Pancreatic Neoplasms
,
Sirolimus
,
analogs & derivatives
,
Young Adult
Comments
Comment on this article
Sign in to comment
Related Documents Log
scite_
Similar content
2,285
Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma.
Authors:
M Davis
,
H Shamoon
Everolimus: A potential therapeutic agent targeting PI3K/Akt pathway in brain insulin system dysfunction and associated neurobehavioral deficits.
Authors:
Seema Bansal
,
Madhunika Agrawal
,
Saniya Mahendiratta
…
Abstract GS2-07: MANTA - A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer
Authors:
P. SCHMID
,
M. Zaiss
,
C Harper-Wynne
See all similar
Cited by
43
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
Authors:
Robert T Jensen
,
Guillaume Cadiot
,
Maria L Brandi
…
Human β-Cell Proliferation and Intracellular Signaling
Authors:
Rohit Kulkarni
,
Ernesto-Bernal Mizrachi
,
Adolfo Ocana
…
Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms
Authors:
Adam Barlow
,
Michael Nicholson
,
Terry Herbert
See all cited by